JAMA February 08, 2006

Low-Fat Dietary Pattern and Risk of Invasive Breast Cancer / Risk of Cardiovascular Disease: The Women's Health Initiative Randomized Controlled Dietary Modification Trial

Ross L. Prentice, Barbara V. Howard, et al. (for the WHI Investigators)

Bottom Line

A massive randomized controlled trial found that a low-fat dietary pattern over 8.1 years did not significantly reduce the risk of invasive breast cancer, coronary heart disease, stroke, or total cardiovascular disease in postmenopausal women.

Key Findings

1. Over an 8.1-year mean follow-up, the incidence of invasive breast cancer was 0.42% (annualized rate) in the low-fat diet group versus 0.45% in the usual diet group, resulting in a non-significant hazard ratio (HR) of 0.91 (95% CI, 0.83-1.01; P=0.09).

2. The dietary intervention had no significant effect on the incidence of coronary heart disease (HR 0.97; 95% CI, 0.90-1.06), stroke (HR 1.02; 95% CI, 0.90-1.15), or total cardiovascular disease (HR 0.98; 95% CI, 0.92-1.05).

3. The intervention group achieved a significant reduction in total fat intake (decreasing from a baseline of ~35% to 24.3% of energy at year 1, and 28.8% at year 6), but failed to achieve the strict protocol target of 20%.

4. Women in the intervention group experienced modest but significant weight loss (mean loss of 2.2 kg at year 1 compared to the control group), which was largely maintained throughout follow-up despite no explicit caloric restriction.

Study Design

Design

RCT

Open-Label

Sample

48,835

Patients

Duration

8.1 yr

Median

Setting

40 US clinical centers

Population Postmenopausal women aged 50-79 years without prior breast cancer, with baseline dietary fat intake ≥32% of total energy.

Intervention Intensive behavioral modification (group and individual sessions) to reduce total fat intake to 20% of calories and increase vegetable/fruit intake to ≥5 servings/d and grains to ≥6 servings/d.

Comparator Usual diet (received generic diet-related educational materials only).

Outcome Incidence of invasive breast cancer and incidence of major cardiovascular disease (CHD and stroke), analyzed and reported in parallel.

Study Limitations

• The intervention group failed to reach the strict target of 20% energy from fat, diluting the potential dietary contrast between the two study arms.

• An 8.1-year follow-up period may be insufficient to capture changes in cancer incidence, given the long latency period of carcinogenesis.

• The intervention focused on reducing total dietary fat without distinguishing between saturated, trans, and healthy unsaturated fats, which is now recognized as a critical factor in both cardiovascular and oncologic nutrition.

• Dietary intake was measured via self-reported food frequency questionnaires and food records, which are inherently vulnerable to recall bias and underreporting.

• The control group naturally decreased their fat intake slightly over the course of the study due to secular health trends in the 1990s and early 2000s, further narrowing the difference between the arms.

Clinical Significance

The WHI Dietary Modification Trial effectively ended the clinical era of prescribing universal 'low-fat' diets for the primary prevention of chronic diseases. By demonstrating that simply restricting total fat intake and increasing fruit and vegetable consumption in postmenopausal women does not significantly alter the trajectory of breast cancer or cardiovascular events over an 8-year span, the trial catalyzed a paradigm shift in nutritional guidelines. Modern dietary counseling now prioritizes diet quality—specifically emphasizing the replacement of saturated and trans fats with healthy poly- and monounsaturated fats—over strict total fat reduction.

Historical Context

For decades, ecological data (such as the Seven Countries Study) and observational cohorts strongly correlated high-fat diets with both cardiovascular disease and certain cancers, prompting aggressive, population-wide public health recommendations in the 1980s and 1990s to cut total dietary fat. The WHI Dietary Modification Trial was launched in 1993 with a staggering budget to definitively test this hypothesis in a massive, federally funded randomized controlled trial. When the null findings were published simultaneously in JAMA in 2006 for breast cancer, cardiovascular disease, and colorectal cancer, they shocked the medical community and radically reshaped modern nutritional science.

Guided Discussion

High-yield insights from every perspective

Med Student

Medical Student

Based on the pathophysiologic theories that prompted the WHI Dietary Modification Trial, by what mechanisms was a low-fat diet originally hypothesized to reduce the risk of both breast cancer and cardiovascular disease?

Key Response

A low-fat diet was hypothesized to reduce CVD risk by lowering LDL cholesterol and improving lipid profiles. For breast cancer, it was thought that lower fat intake and subsequent reduction in adiposity would decrease circulating endogenous estrogens (since adipose tissue converts androgens to estrogens via the aromatase enzyme), thereby decreasing the risk of hormone-receptor-positive breast cancers.

Resident

If a postmenopausal female patient asks if she should adopt a strict 'low-fat' diet to prevent heart attacks and breast cancer, how should you counsel her in light of the WHI trial findings compared to current evidence-based dietary recommendations?

Key Response

The WHI trial showed that a general low-fat dietary pattern did not significantly reduce breast cancer or CVD risk. Residents should counsel patients that modern evidence and guidelines emphasize the *quality* of dietary fat (e.g., a Mediterranean diet high in polyunsaturated and monounsaturated fats, and low in saturated and trans fats) rather than strictly reducing *total* fat intake.

Fellow

Although the primary endpoints for breast cancer and CVD were not significantly reduced in the WHI Dietary Modification Trial, what nuanced limitations regarding the intervention's intensity and the duration of follow-up must a specialist consider before completely discarding the diet-disease hypothesis?

Key Response

Fellows should recognize that the intervention group only reduced fat intake to approximately 29% of daily calories, missing the ambitious 20% target. Furthermore, 8.1 years of follow-up may be an insufficient latency period to observe the primary prevention of complex diseases like breast cancer or CVD in a relatively healthy postmenopausal cohort, and the trial did not isolate saturated versus unsaturated fat reductions.

Attending

The WHI Dietary Modification Trial was a pivotal moment that shifted the medical community's focus away from broad 'low-fat' diets. As an attending teaching preventive medicine, how do you use this trial to explain the evolution of nutritional epidemiology from macronutrient restriction to dietary pattern optimization?

Key Response

This trial is a classic teaching tool demonstrating that isolated macronutrient reduction (total fat) is less impactful than holistic dietary patterns. It highlights the danger of allowing surrogate endpoints (like lipid panels) to drive population-wide dietary advice without hard clinical outcome data from randomized controlled trials, fundamentally changing how we teach preventive cardiology and oncology.

Scholarly Review

Critical appraisal through the lens of expert reviewers and guideline development

PhD

Behavioral dietary interventions often suffer from poor adherence and control group contamination. How did the narrowing difference in dietary fat intake between the WHI intervention and control groups over the 8.1-year follow-up affect the statistical power, and how does this complicate the interpretation of a 'null' finding?

Key Response

The gap in fat intake between groups narrowed significantly over time due to intervention fatigue and the control group adopting secular 'low-fat' trends. This attenuation dilutes the exposure contrast, reducing statistical power and substantially increasing the risk of a Type II error (failing to detect a true effect if one exists), highlighting the immense difficulty of executing and interpreting long-term behavioral RCTs.

Journal Editor

As a peer reviewer assessing the WHI Dietary Modification trial manuscript, what concerns would you raise regarding the reliance on self-reported dietary intake data via food frequency questionnaires (FFQs) and its potential to introduce differential misclassification bias?

Key Response

A tough reviewer would flag that FFQs are notoriously prone to recall bias and social desirability bias. The intervention group, heavily counseled on low-fat eating, might systematically underreport their fat intake compared to controls to please investigators, creating the illusion of a larger dietary separation than actually achieved, thus threatening the internal validity of the exposure measurement.

Guideline Committee

How did the null findings of the WHI Dietary Modification Trial influence the evolution of ACC/AHA cardiovascular prevention guidelines and USPSTF recommendations regarding dietary counseling, specifically shifting the level of evidence away from total fat reduction?

Key Response

The trial provided Level A evidence that reducing *total* fat does not prevent CVD. Consequently, ACC/AHA and USPSTF guidelines updated their recommendations to remove blanket low-fat advice. Current guidelines (e.g., 2019 ACC/AHA Guideline on the Primary Prevention of CVD) now give a Class I recommendation to a diet emphasizing vegetables, fruits, legumes, nuts, whole grains, and fish, specifically advising the replacement of saturated fats with dietary monounsaturated and polyunsaturated fats rather than restricting total fat.

Clinical Landscape

Noteworthy Related Trials

1999

Lyon Diet Heart Study

n = 605 · Circulation

Tested

Mediterranean-type diet rich in alpha-linolenic acid

Population

Patients who had survived a first acute myocardial infarction

Comparator

Prudent Western-type diet (control)

Endpoint

Cardiovascular death and non-fatal acute myocardial infarction

Key result: The Mediterranean dietary pattern maintained up to 4 years after a first myocardial infarction resulted in a 50% to 70% reduction in the risk of recurrent heart disease.

2006

Women's Intervention Nutrition Study (WINS)

n = 2,437 · JNCI

Tested

Dietary intervention to reduce fat intake to 15% of total calories

Population

Postmenopausal women with early-stage, resected breast cancer receiving standard cancer management

Comparator

Standard dietary management (control)

Endpoint

Relapse-free survival

Key result: Women in the dietary fat reduction group had a 24% lower risk of breast cancer relapse compared to the control group, with the most pronounced benefit in hormone receptor-negative cancers.

2013

PREDIMED Trial

n = 7,447 · NEJM

Tested

Mediterranean diet supplemented with extra-virgin olive oil or mixed nuts

Population

Individuals at high cardiovascular risk but with no cardiovascular disease at enrollment

Comparator

Control diet (advice to reduce dietary fat)

Endpoint

Composite of acute myocardial infarction, stroke, or death from cardiovascular causes

Key result: A Mediterranean diet supplemented with extra-virgin olive oil or nuts resulted in an absolute risk reduction of approximately 3 major cardiovascular events per 1000 person-years compared to a low-fat diet.

Tailored to your role

Want this tailored to you?

Add your specialty or training stage to get role-specific takeaways and more questions.

Personalize this analysis